Anna Romert

Title: Anna Romert: Innovator in Retinol Dehydrogenase Research

Introduction

Anna Romert is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of biochemistry, particularly in the study of retinol dehydrogenases. With a total of 3 patents to her name, her work has implications for understanding various biological processes.

Latest Patents

Among her latest patents, Anna has developed isolated proteins that exhibit retinol dehydrogenase activity. These proteins associate with retinol binding receptors and include isolated membrane-associated proteins with a molecular weight ranging from about 30 kD to about 36 kilodaltons, as determined by SDS-PAGE. The proteins demonstrate cis retinol dehydrogenase activity, including 9, 11, or 13 cis retinol dehydrogenase activity, or exhibit cis activity at multiple positions. Additionally, her patents disclose other trans-retinol dehydrogenases and nucleic acid molecules coding for these proteins. One notable discovery is an isolated nucleic acid molecule coding for a 32 kDa protein with 11-cis retinol dehydrogenase activity, which associates with P63, a component of the retinol binding protein receptor.

Career Highlights

Anna Romert is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her innovative research. Her work has garnered attention in the scientific community, contributing to advancements in understanding retinol metabolism and its associated pathways.

Collaborations

Anna has collaborated with notable colleagues, including Andras Simon and Ulf Eriksson, enhancing the scope and impact of her research.

Conclusion

Anna Romert's contributions to the field of retinol dehydrogenase research highlight her innovative spirit and dedication to advancing scientific knowledge. Her patents and ongoing work continue to influence the understanding of biochemical processes related to retinol.